These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33434345)

  • 1. Using stable isotope labeling to advance our understanding of Alzheimer's disease etiology and pathology.
    Hark TJ; Savas JN
    J Neurochem; 2021 Oct; 159(2):318-329. PubMed ID: 33434345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroproteomic tools for battling Alzheimer's disease.
    Veenstra TD
    Proteomics; 2016 Nov; 16(22):2847-2853. PubMed ID: 27633846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capillary Electrophoresis-High Resolution Mass Spectrometry for Measuring In Vivo Arginine Isotope Incorporation in Alzheimer's Disease Mouse Models.
    Adams KJ; Wilson JG; Millington DS; Moseley MA; Colton CA; Thompson JW; Gottschalk WK
    J Am Soc Mass Spectrom; 2021 Jun; 32(6):1448-1458. PubMed ID: 34028275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of isotope labeling liquid chromatography mass spectrometry for mouse urine metabolomics: quantitative metabolomic study of transgenic mice related to Alzheimer's disease.
    Peng J; Guo K; Xia J; Zhou J; Yang J; Westaway D; Wishart DS; Li L
    J Proteome Res; 2014 Oct; 13(10):4457-69. PubMed ID: 25164377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Presymptomatic Changes in the Proteome of Mitochondria-Associated Membrane in the APP/PS1 Mouse Model of Alzheimer's Disease.
    Völgyi K; Badics K; Sialana FJ; Gulyássy P; Udvari EB; Kis V; Drahos L; Lubec G; Kékesi KA; Juhász G
    Mol Neurobiol; 2018 Oct; 55(10):7839-7857. PubMed ID: 29468564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A facile method for expression and purification of (15)N isotope-labeled human Alzheimer's β-amyloid peptides from E. coli for NMR-based structural analysis.
    Sharma SC; Armand T; Ball KA; Chen A; Pelton JG; Wemmer DE; Head-Gordon T
    Protein Expr Purif; 2015 Dec; 116():82-9. PubMed ID: 26231074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
    Savelieff MG; DeToma AS; Derrick JS; Lim MH
    Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease amyloid-β pathology in the lens of the eye.
    Moncaster JA; Moir RD; Burton MA; Chadwick O; Minaeva O; Alvarez VE; Ericsson M; Clark JI; McKee AC; Tanzi RE; Goldstein LE
    Exp Eye Res; 2022 Aug; 221():108974. PubMed ID: 35202705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of apolipoprotein E and amyloid β clearance rates in the mouse brain using bolus stable isotope labeling.
    Basak JM; Kim J; Pyatkivskyy Y; Wildsmith KR; Jiang H; Parsadanian M; Patterson BW; Bateman RJ; Holtzman DM
    Mol Neurodegener; 2012 Apr; 7():14. PubMed ID: 22512932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of human-like extracellular sortilin neuropathology in transgenic Alzheimer's disease model mice and macaques.
    Zhou FQ; Jiang J; Griffith CM; Patrylo PR; Cai H; Chu Y; Yan XX
    Alzheimers Res Ther; 2018 Apr; 10(1):40. PubMed ID: 29690919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isotope-labeled amyloid-β does not transmit to the brain in a prion-like manner after peripheral administration.
    Brackhan M; Calza G; Lundgren K; Bascuñana P; Brüning T; Soliymani R; Kumar R; Abelein A; Baumann M; Lalowski M; Pahnke J
    EMBO Rep; 2022 Jul; 23(7):e54405. PubMed ID: 35620875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effect of the traditional decoction Tian-Si-Yin against Alzheimer's disease via suppression of neuroinflammation.
    Zhou L; Yang C; Liu Z; Chen L; Wang P; Zhou Y; Yuan M; Zhou LT; Wang X; Zhu LQ
    J Ethnopharmacol; 2024 Mar; 321():117569. PubMed ID: 38086513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.
    Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E
    J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brains.
    Gkanatsiou E; Sahlin C; Portelius E; Johannesson M; Söderberg L; Fälting J; Basun H; Möller C; Odergren T; Zetterberg H; Blennow K; Lannfelt L; Brinkmalm G
    Neurosci Lett; 2021 May; 754():135894. PubMed ID: 33848613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Following spatial Aβ aggregation dynamics in evolving Alzheimer's disease pathology by imaging stable isotope labeling kinetics.
    Michno W; Stringer KM; Enzlein T; Passarelli MK; Escrig S; Vitanova K; Wood J; Blennow K; Zetterberg H; Meibom A; Hopf C; Edwards FA; Hanrieder J
    Sci Adv; 2021 Jun; 7(25):. PubMed ID: 34134980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and purification of 15N- and 13C-isotope labeled 40-residue human Alzheimer's β-amyloid peptide for NMR-based structural analysis.
    Long F; Cho W; Ishii Y
    Protein Expr Purif; 2011 Sep; 79(1):16-24. PubMed ID: 21640828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer's disease.
    Boeddrich A; Haenig C; Neuendorf N; Blanc E; Ivanov A; Kirchner M; Schleumann P; Bayraktaroğlu I; Richter M; Molenda CM; Sporbert A; Zenkner M; Schnoegl S; Suenkel C; Schneider LS; Rybak-Wolf A; Kochnowsky B; Byrne LM; Wild EJ; Nielsen JE; Dittmar G; Peters O; Beule D; Wanker EE
    Genome Med; 2023 Jul; 15(1):50. PubMed ID: 37468900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometry analysis of tau and amyloid-beta in iPSC-derived models of Alzheimer's disease and dementia.
    Arber C; Alatza A; Leckey CA; Paterson RW; Zetterberg H; Wray S
    J Neurochem; 2021 Oct; 159(2):305-317. PubMed ID: 33539581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.